Drug Search Results
More Filters [+]

Tioconazole

Alternative Names: tioconazole, tz-3, tioconazol, vagistat-1, vagistat
Latest Update: 2023-08-21
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Cytochrome P450 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Austria | Bangladesh | Brazil | Canada | Chile | Colombia | Cyprus | Dominican Republic | Egypt | Finland | France | Germany | Greece | Hong Kong | India | Indonesia | Ireland | Italy | Korea | Lebanon | Mexico | Morocco | New Zealand | Pakistan | Peru | Philippines | Portugal | Spain | Taiwan | Turkey | Ukraine | United Kingdom | United States | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tioconazole

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title